Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BONE AND JOINT SUPPLEMENTS INDUSTRY
2.1 Summary about Bone and Joint Supplements Industry
2.2 Bone and Joint Supplements Market Trends
2.2.1 Bone and Joint Supplements Production & Consumption Trends
2.2.2 Bone and Joint Supplements Demand Structure Trends
2.3 Bone and Joint Supplements Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Joint Supplements
4.2.2 Bone Supplements
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Elder
4.3.2 Puber
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Joint Supplements
5.2.2 Bone Supplements
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Elder
5.3.2 Puber
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Joint Supplements
6.2.2 Bone Supplements
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Elder
6.3.2 Puber
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Joint Supplements
7.2.2 Bone Supplements
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Elder
7.3.2 Puber
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Joint Supplements
8.2.2 Bone Supplements
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Elder
8.3.2 Puber
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Joint Supplements
9.2.2 Bone Supplements
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Elder
9.3.2 Puber
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Archer Daniels Midland Company
10.1.2 Cargill
10.1.3 DSM
10.1.4 ESM Technologies
10.1.5 BASF
10.1.6 Bergstrom Nutrition
10.1.7 BioScience Nutrition
10.1.8 Ethical Naturals
10.1.9 Kappa Bioscience
10.1.10 Natures Bounty
10.1.11 Reckitt Benckiser
10.2 Bone and Joint Supplements Sales Date of Major Players (2017-2020e)
10.2.1 Archer Daniels Midland Company
10.2.2 Cargill
10.2.3 DSM
10.2.4 ESM Technologies
10.2.5 BASF
10.2.6 Bergstrom Nutrition
10.2.7 BioScience Nutrition
10.2.8 Ethical Naturals
10.2.9 Kappa Bioscience
10.2.10 Natures Bounty
10.2.11 Reckitt Benckiser
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
